ADAMA Ltd. (SHE:000553)
6.20
-0.03 (-0.48%)
Apr 29, 2026, 3:04 PM CST
ADAMA Revenue
In the year 2025, ADAMA had annual revenue of 28.94B CNY, down -1.84%. ADAMA had revenue of 7.27B in the quarter ending December 31, 2025, a decrease of -8.77%.
Revenue
28.94B
Revenue Growth
-1.84%
P/S Ratio
0.48
Revenue / Employee
3.99M
Employees
7,255
Market Cap
13.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.94B | -543.46M | -1.84% |
| Dec 31, 2024 | 29.49B | -3.29B | -10.04% |
| Dec 31, 2023 | 32.78B | -4.60B | -12.31% |
| Dec 31, 2022 | 37.38B | 6.34B | 20.44% |
| Dec 31, 2021 | 31.04B | 2.59B | 9.12% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Guangxin Agrochemical | 3.46B |
| Shenzhen Batian Ecotypic Engineering | 5.06B |
| Stanley Agriculture Group | 12.94B |
| Nantong Jiangshan Agrochemical & Chemicals | 5.65B |
| CAC Nantong Chemical | 5.10B |
| Zhejiang Xinan Chemical Industrial Group Co.,Ltd | 14.62B |
| Chengdu Wintrue Holding | 21.40B |
| Shenzhen Noposion Crop Science | 6.31B |
ADAMA News
- 4 weeks ago - ADAMA Earnings Call Transcript: Q4 2025 - Transcripts
- 8 months ago - ADAMA Earnings Call Transcript: Q2 2025 - Transcripts
- 1 year ago - ADAMA Earnings Call Transcript: Q4 2024 - Transcripts
- 1 year ago - ADAMA Earnings Call Transcript: Q3 2024 - Transcripts
- 1 year ago - ADAMA Earnings Call Transcript: Q2 2024 - Transcripts
- 2 years ago - ADAMA Earnings Call Transcript: Q1 2024 - Transcripts
- 2 years ago - ADAMA Earnings Call Transcript: Q4 2023 - Transcripts
- 2 years ago - ADAMA Earnings Call Transcript: Q3 2023 - Transcripts